Christina Smolke is the co-founder and CEO of Antheia. Antheia is a synthetic biology company -- they’re in the business of genetically engineering microorganisms to produce commercial products.
Christina’s problem is this: How do you turn yeast cells into tiny factories to create the active ingredients in generic drugs.** If Christina and her team solve this problem, they won’t solve the drug shortage problem entirely. But they might help make it better.
See omnystudio.com/listener) for privacy information.
